6 Recruiting Studies Using Ruxolitinib Cream
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Ruxolitinib Cream
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
📍 Investigative Site US020 — Phoenix, Arizona
Hidradenitis Suppurativa
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)
📍 Investigative Site US257 — Birmingham, Alabama
Hidradenitis Suppurativa
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
📍 University of Alabama At Birmingham-School of Medicine — Birmingham, Alabama
NonSegmental Vitiligo
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
📍 Syneos Health (remote site) — Morrisville, North Carolina
Pregnancy Related
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
📍 Saguaro Dermatology — Phoenix, Arizona
Hidradenitis Suppurativa
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
📍 Syneos Health (remote site) — Morrisville, North Carolina
Pregnancy Related
View Study & Checklist ➔